Dr. Reddy�s
May 22, 2012 at 12:51 | Source: BizTech2.com
May 08, 2012 at 08:21 | Source: CNBC-TV18
May 03, 2012 at 15:04 | Source: Moneycontrol.com
Apr 09, 2012 at 14:46 | Source: Moneycontrol.com
Mar 30, 2012 at 11:25 | Source: Moneycontrol.com
Mar 28, 2012 at 17:28 | Source: CNBC-TV18
Interact & exchange stock tips & market info »
Related News »
Dr. Reddy's Laboratories (RDY), India's second-largest pharmaceutical company, recently reported a fourth-quarter and full-year 2012 performance that beat expectations on revenues but missed estimates on earnings. Revenues for the full year came in at $1.9 ...
May 25, 2012 at 15:28 | Source: Seekingalpha.com
Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy's ANDA approval by the United States Food & Drug ...
May 21, 2012 at 06:00 | Source: News-Medical.Net
NEW YORK, May 22, 2012 /PRNewswire via COMTEX/ -- Genpact Limited (NYSE:G) , a global leader in business process and technology management, today announced that it has signed an agreement with Dr. Reddy's Laboratories (NYSE:RDY) to provide ...
May 22, 2012 at 06:06 | Source: Marketwatch
Dr. Reddy’s Laboratories (RDY) recently announced the U.S. launch of a generic version of Bristol-Myers Squibb & Co.’s (BMY) blood thinner, Plavix. The U.S. Food and Drug Administration (:FDA) approved the Abbreviated New Drug Application ...
May 18, 2012 at 16:40 | Source: Yahoo Finance
HYDERABAD, India, May 21, 2012 (BUSINESS WIRE) -- Dr. Reddy's Laboratories (NYSE:RDY) announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy's ...
May 21, 2012 at 04:12 | Source: Marketwatch
New Delhi, May 21 (PTI) Drug firm Dr Reddy''s Laboratories today said it has launched its generic version of lansoprazole delayed-release capsules used for treating acidity and heartburns in the US market. The company has launched over-the-counter ...
May 21, 2012 at 12:34 | Source: MSN India
Dr. Reddy’s Laboratories (NYSE: RDY) has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg, a bioequivalent generic version of Sanofi's (NYSE: SNY) PLAVIX®, in the U.S. market on May 18, 2012. The ANDAs for Clopidogrel Tablets USP, 75 mg & 300 mg are ...
May 18, 2012 at 10:43 | Source: StreetInsider.com
Dr. Reddy's Laboratories Limited - SWOT Analysis company profile is the essential source for top-level company data and information. Dr. Reddy's Laboratories Limited - SWOT Analysis examines the company's key business structure and operations, history and ...
May 18, 2012 at 04:30 | Source: Transworld News
Dr Reddy’s Laboratories may soon launch a low-cost version of blood thinning drug Plavix in the US, the world’s largest drug market. An antiplatelet agent used to reduce the risk of stroke or heart attack in patients with atherosclerosis, Plavix has a ...
May 16, 2012 at 18:59 | Source: Business Standard
Chicago, IL - May 21, 2012 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently ...
May 21, 2012 at 14:28 | Source: NASDAQ